Clinical Trial Testing TH-302 in Combination With Gemcitabine in Previously Untreated Subjects With Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma
Clinical trial NCT01746979 · COMPLETED
Trial details
- NCT number
- NCT01746979
- Sponsor
- ImmunoGenesis
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-01
- Primary completion
- 2016-02-01
- Enrollment
- 693
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.